Hepatitis B Immunisation: A Two-part Study Investigating Antigen Specific B Cell Receptors

Trial Profile

Hepatitis B Immunisation: A Two-part Study Investigating Antigen Specific B Cell Receptors

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Hepatitis B vaccine recombinant (HBvaxPro) (Primary) ; Hepatitis B vaccine
  • Indications Hepatitis B
  • Focus Biomarker; Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 23 Oct 2013 Accrual to date is 93% according to United Kingdom Clinical Research Network.
    • 12 Sep 2013 Accrual to date is 68% according to United Kingdom Clinical Research Network.
    • 01 Aug 2013 Planned end date changed from 1 Aug 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top